HNWAG
NEXI

High Net Worth Advisory Group’s NexImmune, Inc. Common Stock NEXI Stock Holding History

High Net Worth Advisory Group’s Portfolio NEXI Stock Details NEXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-20
Closed -$2K – 737
2021
Q4 		$2K Buy
+20
New +$4.8K ﹤0.01% 659

Other funds holding NEXI

ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
AO
Allen Operations New York $670M AUM 26.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

High Net Worth Advisory Group's NEXI Position: Q1 2022 in Review

High Net Worth Advisory Group sold out of NexImmune, Inc. Common Stock (NEXI) in Q1 2022, closing a stake of 20 shares — an estimated $2K sold.

High Net Worth Advisory Group first reported a position in NEXI in Q4 2021 and held it in 1 quarter. The position peaked at $2K in Q4 2021. 52 funds tracked by Wall St. Rank hold NEXI as of Q1 2022.

  • High Net Worth Advisory Group reported no remaining NexImmune, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • High Net Worth Advisory Group sold 20 NexImmune, Inc. Common Stock shares in Q1 2022, an estimated $2K.
  • High Net Worth Advisory Group first reported a position in NexImmune, Inc. Common Stock in Q4 2021 and held it in 1 quarter.
  • High Net Worth Advisory Group's NexImmune, Inc. Common Stock position peaked at $2K in Q4 2021.
  • 52 funds tracked by Wall St. Rank held NexImmune, Inc. Common Stock as of Q1 2022.

Based on High Net Worth Advisory Group's 13F filing for Q1 2022, filed 13 May 2022.